SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-24-024002
Filing Date
2024-05-02
Accepted
2024-05-02 16:17:34
Documents
1
Period of Report
2024-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 4062
  Complete submission text file 0001140361-24-024002.txt   5582
Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540 800-208-3343
PDS Biotechnology Corp (Issuer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 135 BEAVER STREET C/O INTERLEUKIN GENETICS, INC. WALTHAM MA 02453
Business Address
Toutain Stephan (Reporting) CIK: 0001681658 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37568 | Film No.: 24908561